The new injectable facility of Eugia Steriles, a subsidiary of Eugia Pharma Specialities and a stepdown unit of the company, situated at Anakapalli District of Andhra Pradesh was inspected by the US FDA from March 28 to April 5 this year.
Aurobindo Pharma on Wednesday said its unit has received the first product approval from the US Food and Drug Administration for a generic anaesthesia medication. The new injectable facility of Eugia Steriles, a subsidiary of Eugia Pharma Specialities and a stepdown unit of the company, situated at Anakapalli District of Andhra Pradesh was inspected by the US FDA from March 28 to April 5 this year.
The plant has now received its first product approval from the USFDA for Lidocaine Hydrochloride Injection, Aurobindo Pharma said in a regulatory filing.
Shares of Aurobindo Pharma on Wednesday ended 0.74 per cent down at Rs 1,507.20 apiece on the BSE.
Comments
0 comment